Modified Cardiac Rehab May Cut Mortality Risk for Stroke Survivors
As part of stroke recovery program, modified cardiac rehab may lower all-cause one-year mortality, improve overall and cardiovascular function.
General Cardiology
Risk of Cardiotoxicity With Doxorubicin for DLBCL Does Not Include Ischemic Heart Disease, Stroke
A study compared patients with diffuse large B-cell lymphoma with a 1:10 cohort from the general population to determine the risk of cardiovascular events in patients receiving doxorubicin-containing regimens.
Risk for Myocarditis Low After Third Dose of BNT162b2 Vaccine
Incidence of myocarditis among young men estimated to be 6.43 and 11.25 per 100,000 vaccines in the week, two weeks after third dose.
Reduced Cardiovascular Morbidity Seen in Patients With Hemophilia
Researchers sought to determine the incidence of fatal and nonfatal CVD during 5 years of follow up in adults with hemophilia.
Anemia Linked to Greater Risk for Mortality in Patients With Atrial Fibrillation
Researchers analyzed the association between anemia and CV mortality, all-cause mortality, and major bleeding in patients with atrial fibrillation.
Daratumumab With Carfilzomib May Offer Cardioprotective Benefit for Multiple Myeloma
Researchers sought to determine whether adding daratumumab to carfilzomib would help prevent cardiovascular adverse events in patients with relapsed/refractory multiple myeloma.
Gene Therapy Candidate Designated Orphan Drug for Buerger Disease
Buerger disease typically affects young or middle aged male cigarette smokers.
USPSTF: Starting Aspirin in Patients 60 or Older for Primary CVD Prevention Not Recommended
Starting aspirin in patients 60 years or older to prevent a first heart attack or stroke is not recommended.
Clopidogrel Monotherapy Associated With Better Vascular Function and Hemostatic Measurements Than Aspirin in Patients With Coronary Artery Disease
Researchers sought to determine whether clopidogrel would be more effective than aspirin monotherapy for patients with CAD.
Clopidogrel Preferred to Reduce Heart Disease Risk in Patients With HIV
Researchers sought to determine whether clopidogrel would be preferred over aspirin to reduce cardiovascular risk in patients with HIV.
- Loading...
Loading...
Next post in General Hematology
Loading... 
Loading...